{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    6,
    8,
    17,
    20,
    25,
    26,
    29,
    37,
    38,
    39
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 0.8,
  "amendmentDetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_3.1",
        "affectedSection": "Section 1.3 Schedule of Activities (SoA), Table 1",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Addition of a footnote to the Schedule of Activities to reference new procedures for screening-only sites in the US."
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_3.1",
        "affectedSection": "Section 4.2 - Scientific Rationale for Study Design",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Modified the number of days for zinc discontinuation to align with other protocol sections."
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_3.1",
        "affectedSection": "Section 8 - Study Assessments and Procedures",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Introduction of screening-only sites in the US to facilitate participant recruitment and lessen participant inconvenience."
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_3.1",
        "reasonText": "To clarify study procedures occurring across different sites in the US, so as to facilitate participant recruitment across different regions of the US, and to lessen inconvenience for participants without compromising the quality of the study.",
        "category": "Operational",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_3.1",
        "reasonText": "To align the number of days with the mention of zinc discontinuation elsewhere in the protocol.",
        "category": "Administrative",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_3.1",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "Addition of text to the footnote to state that procedures specific to screening sites (only in the US) detailed in Section 8",
        "summary": "A footnote was added to the Schedule of Activities table to reference the new screening-only site procedures."
      },
      {
        "id": "change_2",
        "amendmentId": "amend_3.1",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "4.2",
        "beforeText": "...the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 30 days after discontinuation of zinc.",
        "afterText": "...the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 21 days after discontinuation of zinc.",
        "summary": "Changed the number of days from 30 to 21 for zinc discontinuation effect to align with other parts of the protocol."
      },
      {
        "id": "change_3",
        "amendmentId": "amend_3.1",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "8",
        "afterText": "Addition of text applicable only to the US that details the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures.",
        "summary": "Added text to allow US sites to act as screening-only sites to improve recruitment."
      }
    ],
    "summary": {
      "impactCount": 3,
      "reasonCount": 2,
      "changeCount": 3
    }
  }
}